Repare Therapeutics Inc. — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2024)

-$84.7M

Total Assets (FY2024)

$176.5M

Total Equity (FY2024)

$151.1M

Cash Flows from Operating Activities (FY2024)

-$76.4M

Source: Repare Therapeutics Inc. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.